Key takeaways
- Bioidentical is about structure. BHRT uses hormones identical to your own, and compounded versions are often marketed as natural without that meaning safer.
- FDA-approved options already exist. The National Academies note dozens of approved estrogen, progesterone and testosterone products.
- Compounded BHRT lacks data. A 2022 review found compounded hormones lack pharmacokinetic, safety and efficacy data, and flagged pellets as riskier still.
- Route matters. A systematic review of 51 studies found oral estrogen carries a higher clot risk than transdermal.
- Timing matters. The 2022 NAMS statement finds the benefit-risk ratio favorable before 60 or within 10 years of menopause.
The short answer
What is BHRT?
BHRT is bioidentical hormone replacement therapy. “Bioidentical” means the hormone molecule has the same structure as the one your own body makes: estradiol that is estradiol, progesterone that is progesterone. The National Academies define compounded versions as preparations marketed as “bioidentical” or “natural”, and MedlinePlus on hormone therapy is a useful non-commercial reference.
That is a genuine distinction from older preparations such as conjugated equine estrogens and medroxyprogesterone acetate, the combination tested in the Women’s Health Initiative, which are not structurally identical to human hormones. Our bioidentical vs synthetic comparison goes through that difference in detail.
What bioidentical means
What Are Bioidentical Hormones?
Bioidentical hormones are hormones whose structure matches your own, and the word is a statement about structure and nothing more. A bioidentical hormone is usually synthesized in a laboratory from plant sterols. It is not harvested from a plant and it is not less processed than anything else; the word describes the end molecule, not its origin story.
Why the structure matters anyway
The structure matters anyway because receptors are shape-specific. A molecule identical to your own estradiol binds the receptor the way your own estradiol does, while a structurally different molecule may behave differently and carry a different risk profile. In a French cohort of 80,377 women, estrogen with micronized progesterone showed no rise in breast cancer risk, while estrogen with other synthetic progestins did, which is one reason many clinicians favor progesterone. Transdermal estradiol is favored for a separate reason: a 2023 systematic review of 51 studies found venous clots were the clearest difference, higher with oral estrogen.
Where the marketing overreaches
The marketing overreaches when “bioidentical” is used to imply natural, and natural to imply safe. Neither step follows. A 2022 review describes women turning to compounded bioidenticals in the misguided belief of greater safety. These are prescription hormones with real effects and real risks, which is the point of taking them under supervision.
Approved vs compounded
FDA-approved bioidenticals vs compounded BHRT
FDA-approved bioidenticals vs compounded BHRT is the distinction most BHRT pages skip, and it is the most useful thing on this page. The National Academies report notes the FDA has approved dozens of hormone products, including estrogen, progesterone and testosterone, reviewed for safety and efficacy.
| FDA-approved bioidentical | Custom-compounded BHRT | |
|---|---|---|
| Examples | Estradiol patches, gels, micronized progesterone | Custom creams, troches, pellets |
| FDA reviewed | Yes: safety, efficacy, manufacturing | No |
| Dose consistency | Standardized and verified | Varies by pharmacy and batch |
| Evidence base | Extensive clinical trial data | Limited |
| Custom dosing | Fixed strengths | Flexible |
The expert concern is about custom-compounded hormones specifically, not about bioidentical hormones as a class. A 2022 review in Cancer Journal noted that compounded bioidentical hormones lack data on pharmacokinetics, safety and efficacy, and recommended restricting them to women with allergies or a dose or formulation that approved products do not offer. That is the legitimate place for compounding. It is not a better default.
What it treats
What BHRT is used for
BHRT is used for menopause symptoms in women and for confirmed low testosterone in men.
In women
In women, BHRT is used for hot flashes, night sweats, sleep disruption, vaginal dryness and bone loss associated with perimenopause and menopause. The North American Menopause Society calls hormone therapy the most effective treatment for hot flashes and night sweats and says it prevents bone loss and fracture. Progesterone is added to protect the uterine lining in anyone with a uterus who takes systemic estrogen, because estrogen alone raises the risk of endometrial cancer.
In men
In men, BHRT means testosterone replacement for clinically low testosterone confirmed on repeated morning blood tests alongside symptoms, not on symptoms alone, and not on a single borderline result. Our TRT guide covers that path in detail.
What decides whether it is appropriate
What decides whether BHRT is appropriate is labs, symptoms, medical history, age, time since menopause where relevant, and personal risk factors. The NAMS statement asks for individualized treatment with periodic re-evaluation, so the decision is revisited, not made once.
BHRT vs HRT
BHRT vs HRT: is there a real difference?
BHRT vs HRT is a question about labels more than about medicine. HRT is the umbrella term for any hormone replacement. BHRT is HRT that uses hormones with the same molecular structure as your own, such as estradiol, micronized progesterone and testosterone. Older HRT regimens, including the conjugated equine estrogens and medroxyprogesterone acetate used in the Women's Health Initiative trial, are not bioidentical. Our HRT vs TRT explainer sorts out the other common label confusion.
The difference that matters clinically is not the BHRT label itself but three choices inside it. The first is the estrogen route: a patch or gel instead of a pill, which carries a lower clot risk. The second is the progestogen: micronized progesterone instead of an older synthetic progestin, which had a more favorable breast cancer signal in the E3N cohort. The third is the source: an FDA-approved product with verified dosing instead of a compounded preparation. A plan built from FDA-approved bioidentical hormones answers most of what people mean when they ask for BHRT. For the trial evidence on menopause hormone therapy as a whole, see our menopause hormone therapy guide; for a practical starting point on treatment, see HRT for women.
It also explains why two clinics can both offer BHRT and mean entirely different things. One may prescribe a standard estradiol patch and progesterone capsule and monitor them with labs; another may sell a compounded pellet package. Ask which products, which routes, and how the dose will be checked before you compare clinics.
Candidacy
BHRT for women and BHRT for men: who is a candidate?
BHRT for women and BHRT for men each have a typical candidate: a woman with bothersome menopause symptoms, or a man with confirmed low testosterone and consistent symptoms.
BHRT for women
For BHRT for women, the typical candidate is a woman in perimenopause or menopause with bothersome hot flashes, night sweats, sleep disruption, vaginal dryness or early bone loss, who has no history of certain cancers, blood clots or stroke. Timing matters: starting before 60 or within 10 years of menopause onset gives the most favorable benefit-risk ratio in the current evidence. Women with only vaginal or urinary symptoms are often better served by low-dose vaginal estrogen than by systemic BHRT. Our guide to perimenopause vs menopause helps place where you are.
BHRT for men
For BHRT for men, the treatment is bioidentical testosterone, and the bar for starting it is specific. The Endocrine Society recommends diagnosing low testosterone only in men with consistent symptoms and unequivocally low levels on fasting morning blood tests, confirmed by a repeat test, and recommends against starting it in men planning fertility soon or with prostate or breast cancer, an elevated hematocrit, untreated severe sleep apnea or a recent heart attack or stroke (Bhasin et al., Journal of Clinical Endocrinology & Metabolism, 2018). See the signs of low testosterone for the symptom side.
Forms
What Are the Types of BHRT? Pills, Patches, Gels, Creams, Injections and Pellets
The types of BHRT include pills, patches, gels, creams, injections and pellets, because BHRT is not one product. The same bioidentical hormone can reach the body several ways, and the route changes how steady the levels are, how easy the dose is to adjust, and some of the risks, such as the higher clot risk of oral estrogen.
| Form | Common BHRT hormones | FDA-approved versions exist? | Practical notes |
|---|---|---|---|
| Oral capsule or tablet | Micronized progesterone, estradiol | Yes | Simple; oral estrogen passes through the liver first |
| Skin patch | Estradiol | Yes | Steady levels; changed once or twice a week |
| Gel or spray | Estradiol, testosterone (men) | Yes | Daily; avoid skin contact with partners and children after applying |
| Vaginal cream, ring or insert | Estradiol | Yes | For local dryness and urinary symptoms, with low absorption |
| Injection | Testosterone (men) | Yes | Weekly or every-other-week schedules are common |
| Compounded cream or troche | Estradiol, estriol, progesterone, testosterone | No | Flexible strengths, but dose consistency varies |
| Pellet implant | Estradiol, testosterone | Testosterone pellets for men only | Cannot be adjusted or removed easily once placed |
For most patients, a combination of FDA-approved transdermal estradiol and oral micronized progesterone covers what custom compounding promises: bioidentical molecules, adjustable doses, and a large evidence base. Our estrogen patch vs pill comparison covers that route choice. Compounding is reserved for a specific reason the standard products cannot meet.
What BHRT is made from
What is BHRT made from?
BHRT is made from plant sterols, usually diosgenin from wild yam or sterols from soy, which a laboratory chemically converts into estradiol, progesterone or testosterone. The plant is the raw material, not the medicine: in a placebo-controlled trial of wild yam cream, which contains diosgenin, the cream did not change hormone levels and worked no better than placebo for menopause symptoms.
The same synthesis feeds both FDA-approved bioidentical products and compounding pharmacies. What differs is what happens after the active ingredient is made. An FDA-approved estradiol patch or micronized progesterone capsule is manufactured to a verified strength in every unit; a compounded cream, troche or pellet is mixed for one prescription, and the National Academies’ 2020 review examined whether evidence supports the safety and effectiveness claims made for those preparations.
So the honest answer to what BHRT is made from is: the same plant-derived hormone molecules either way. The source does not make BHRT natural or safer; the product it ends up in decides how well tested it is.
BHRT pellets
How Do BHRT Pellets Work, and Can the Dose Be Undone?
BHRT pellets work as small implants of compressed hormone placed under the skin that slowly release the hormone for a long-acting effect, and the dose cannot be undone once one is placed. The appeal is convenience: no daily gel or weekly patch. The trade-off is control.
What the evidence says about bioidentical hormone pellets
The evidence says bioidentical hormone pellets are approved for one use only: testosterone pellets for men with testosterone deficiency are FDA-approved. Estradiol pellets and custom pellet blends for women are compounded and are not FDA-approved. A 2022 review in Cancer Journal warned that pellets can produce hormone levels above the normal physiological range, and that this raises more safety concerns than other compounded hormone forms. Even approved testosterone pellets need watching: in a chart review of 228 men, an estimated 17.3% developed a high red cell count by 12 months.
Why the dose cannot be adjusted
A pellet dose cannot be lowered once it is placed. If side effects appear, a patch can come off the same day; a pellet keeps releasing until it dissolves. That is why most clinicians start with an adjustable form, such as a transdermal estradiol patch or gel, and treat pellets as a narrow option rather than a default.
BHRT pellets suit a small group of patients. For most people, an adjustable FDA-approved form gives the same bioidentical molecule with the option to change course.
The evidence
Is BHRT safe? What the major reviews say
Is BHRT safe depends on which BHRT you mean, and the major reviews say so directly. For FDA-approved hormone therapy, the 2022 position statement from the North American Menopause Society (now The Menopause Society) concludes that hormone therapy remains the most effective treatment for hot flashes and the genitourinary syndrome of menopause, and that it prevents bone loss and fracture. Its risks differ by type, dose, duration, route, timing of initiation and whether a progestogen is used. For women younger than 60 or within 10 years of menopause without contraindications, the benefit-risk ratio is favorable; for women starting later it appears less favorable (NAMS, Menopause, 2022). Our page on HRT and breast cancer risk covers that question in depth.
Compounded BHRT has a thinner record. In a 2020 report, the National Academies of Sciences, Engineering, and Medicine reviewed the safety, effectiveness and use of compounded bioidentical hormone therapy. It noted that the FDA has approved dozens of hormone products, including estrogen, progesterone and testosterone, that compounded preparations are often marketed as bioidentical or natural, and that the clinical utility of these preparations is a substantial public health concern (NASEM, 2020). In short, the major reviews support FDA-approved hormone therapy for the right patient and raise concerns about compounded BHRT.
Side effects
BHRT side effects and what to watch for
BHRT side effects are mostly dose-related, which is why doses are started conservatively and adjusted against symptoms and labs.
Common in women
Common side effects in women include breast tenderness, stomach upset, headache, mood changes and dizziness, as listed for estrogen and progesterone. Unusual vaginal bleeding should be reported. Progesterone may cause drowsiness, which is one reason it is often taken at bedtime.
Common in men
Common side effects in men include acne, fluid retention and a rise in red blood cell count (hematocrit), all listed on the testosterone pellet label. Testosterone also suppresses sperm production, which is why the Endocrine Society guideline advises against it for men planning fertility soon and calls for hematocrit and PSA monitoring. Our guide to lowering hematocrit explains what happens when it climbs.
When to call your clinician
Call your clinician promptly for leg pain or swelling, chest pain or sudden breathlessness, a severe headache, a new breast lump, or unexpected vaginal bleeding after menopause, rather than waiting until the next visit. These are the serious symptoms MedlinePlus lists for estrogen, and our safety information page explains how to report a reaction.
Timing
How Long Does BHRT Take to Work, and How Long Do You Stay on It?
How long BHRT takes to work varies by symptom, and how long you stay on it is reviewed at least yearly.
How long it takes
How long BHRT takes depends on the symptom and the person. In women, hot flashes and night sweats are usually the first target, while vaginal symptoms can take longer and bone benefits accrue over years; our guide to how long HRT takes to start working goes week by week. In men, a review of testosterone timelines found effects on sexual interest after about 3 weeks, mood after 3 to 6 weeks, and changes in fat mass, lean mass and strength within 12 to 16 weeks.
How long to stay on it
How long you stay on BHRT is reviewed over time, and monitoring is part of the treatment, not an extra. Women on systemic BHRT are reviewed for symptom control, bleeding pattern and blood pressure, with labs when the clinical picture calls for them. Men on testosterone have testosterone, hematocrit and PSA checked at baseline and at intervals, as the Endocrine Society guideline recommends, because those markers flag the main risks early and guide any change in dose.
There is no fixed stopping date. The NAMS statement advises that longer durations be for documented reasons such as persistent hot flashes, with shared decision-making and periodic re-evaluation of benefits and risks. In practice that means a yearly conversation, not an automatic renewal.
Risks
What Are the Negatives of Bioidentical Hormones, and Who Should Not Take Them?
The negatives of bioidentical hormones are the same real risks as other hormone therapy, and they vary by hormone, dose, route and the person taking them. Oral estrogen raises clotting risk more than transdermal estrogen; a 2023 systematic review of 51 studies found venous thromboembolism was the clearest difference between the two routes. Risk profiles also differ with age and with years since menopause.
Hormone therapy is generally avoided in people with unexplained vaginal bleeding, certain cancers, a past stroke, heart attack or blood clots, or liver disease, though these are discussions with a clinician rather than absolute rules in every case.
Bioidentical describes the structure of the molecule, not its safety. FDA-approved bioidentical hormones, such as transdermal estradiol and micronized progesterone, started at the right time and monitored, carry the strongest evidence. Custom-compounded creams and pellets are not FDA-approved and have the least evidence behind them.
Our Approach
BHRT at Protocol Health
BHRT at Protocol Health starts with a history, symptoms and baseline labs, and every plan is reviewed after treatment begins. We favor FDA-approved bioidentical products where they fit, and we explain why when they do not.
For women, that runs through our HRT for women program; for men, through HRT for men. If you are unsure which applies, the short quiz routes you to the right first visit.
BHRT at Protocol Health is the same evidence-first approach described above: the right hormone, route and source for your history, with monitoring that continues after the first prescription.
Bottom Line
The Bottom Line
BHRT is a label for hormones that match your own molecules, and whether it is a good choice depends on the product, route and timing.
- Bioidentical describes structure, not safety. These are prescription hormones with real risks that need supervision.
- Many bioidenticals are FDA-approved. Estradiol patches, gels and micronized progesterone have been reviewed for safety and efficacy.
- Compounded BHRT has thin evidence. National Academies and expert reviews flag missing safety, dosing and efficacy data.
- Route and progestogen matter most. Transdermal estrogen carries less clot risk, and micronized progesterone had a better breast signal in a large cohort.
- Pellets trade control for convenience. A pellet dose cannot be lowered once placed, and only testosterone pellets for men are approved.
- Timing shapes the benefit-risk balance. Starting before 60 or within 10 years of menopause looks most favorable.
FAQ
Frequently Asked Questions
What does BHRT stand for?
BHRT stands for bioidentical hormone replacement therapy: hormone therapy using molecules structurally identical to the hormones your body produces, such as estradiol and progesterone. Compounded versions are often marketed as bioidentical or natural, but the term itself only describes structure.
Is BHRT safer than traditional HRT?
Not automatically. Transdermal estradiol carries a lower clot risk than oral estrogen, which is a benefit of the route rather than of the word bioidentical. Micronized progesterone had a better breast cancer signal than other progestins in a large observational cohort. Custom-compounded versions have less evidence behind them, not more.
Is BHRT FDA-approved?
Many bioidentical hormones are, including estradiol patches and gels and micronized progesterone. Custom-compounded bioidentical preparations are not FDA-approved and, per a 2022 review, lack data on pharmacokinetics, safety and efficacy.
What is the difference between BHRT and HRT?
HRT is the umbrella term for hormone replacement, and BHRT specifies that the hormones are structurally identical to your own. All BHRT is HRT; not all HRT is bioidentical, such as the conjugated equine estrogens used in the WHI.
Are bioidentical hormones natural?
No, not in the sense most people mean. They are usually synthesized in a laboratory from plant sterols, and a wild yam cream trial showed the raw plant material itself does not change hormone levels. “Bioidentical” describes the structure of the final molecule.
Who should not take BHRT?
BHRT is generally avoided with unexplained vaginal bleeding, certain cancers, a past stroke, heart attack or blood clots, or liver disease. For men, the Endocrine Society advises against testosterone with prostate or breast cancer, a high hematocrit or near-term fertility plans. These are conversations with a clinician rather than universal rules.
What are the negatives of bioidentical hormones?
The negatives of bioidentical hormones are the same core risks as other hormone therapy: blood clots with oral estrogen, endometrial cancer risk if estrogen is given without progesterone to a woman with a uterus, and dose-related side effects such as breast tenderness or, in men, a rising red blood cell count. Compounded versions add uncertainty about dose consistency, and pellets cannot be adjusted once placed.
Are BHRT pellets FDA-approved?
Only testosterone pellets for men are FDA-approved. Estradiol pellets and most custom pellet blends for women are compounded and are not FDA-approved. Pellets cannot easily be adjusted or removed once placed, and a 2022 review warned they can push hormone levels above the normal range.
Explore
Related at Protocol Health
See if hormone therapy fits your situationMedical disclaimer
This article is for education only and is not medical advice, diagnosis, or treatment. Talk to a licensed clinician before starting, stopping, or changing any medication.
Important safety information
References
- National Academies of Sciences, Engineering, and Medicine, 2020. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. National Academies Press. PMID 33048485. https://pubmed.ncbi.nlm.nih.gov/33048485/
- Pinkerton JV, 2022. Concerns About Compounded Bioidentical Menopausal Hormone Therapy. Cancer J. PMID 35594471. https://pubmed.ncbi.nlm.nih.gov/35594471/
- Goldštajn MŠ et al., 2023. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review. Arch Gynecol Obstet. PMID 35713694. https://pubmed.ncbi.nlm.nih.gov/35713694/
- The North American Menopause Society Advisory Panel, 2022. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. PMID 35797481. https://pubmed.ncbi.nlm.nih.gov/35797481/
- MedlinePlus (U.S. National Library of Medicine). Hormone Therapy for Menopause. https://medlineplus.gov/hormonetherapyformenopause.html
- Rossouw JE et al., 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. PMID 12117397. https://pubmed.ncbi.nlm.nih.gov/12117397/
- Fournier A et al., 2008. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. PMID 17333341. https://pubmed.ncbi.nlm.nih.gov/17333341/
- Bhasin S et al., 2018. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. PMID 29562364. https://pubmed.ncbi.nlm.nih.gov/29562364/
- MedlinePlus (U.S. National Library of Medicine). Estrogen drug information. https://medlineplus.gov/druginfo/meds/a682922.html
- Komesaroff PA et al., 2001. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric. PMID 11428178. https://pubmed.ncbi.nlm.nih.gov/11428178/
Show all 14 references
- DailyMed (U.S. National Library of Medicine). TESTOPEL (testosterone) pellet prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03b9c0b1-5884-11e4-8ed6-0800200c9a66
- Rotker KL et al., 2018. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia. Asian J Androl. PMID 29205178. https://pubmed.ncbi.nlm.nih.gov/29205178/
- MedlinePlus (U.S. National Library of Medicine). Progesterone drug information. https://medlineplus.gov/druginfo/meds/a604017.html
- Saad F et al., 2011. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol. PMID 21753068. https://pubmed.ncbi.nlm.nih.gov/21753068/
Why trust our physicians
Every article is reviewed by a licensed physician on our medical team and is kept current by our editorial team. Read our editorial policy and our medical review process.
- Medically reviewed by
- Richard Dentico, MD on
- Written by
- Protocol Health Editorial Team
- First published
- Last updated
See an error? Email care@protocolhealthmd.com and we will review it.
More on Women's Hormones & HRT
- Estradiol Levels in Men: Normal Range, High and Low
- Progesterone Side Effects: What's Common, What's Serious
- How to Choose a Menopause Doctor in Westchester, NY
- Can You Take Progesterone Without Estrogen?
